If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
58.10    0.00 (0.00%)
Bid:
57.00
Ask:
59.00
Spread: 2.00 (3.509%)
Market Cap: £47.31m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Update

27 Mar 2008 07:02

Flomerics Group PLC27 March 2008 Flomerics Group PLC ("Flomerics" or "the Company") Update Flomerics, the global supplier of specialist simulation software for electronicsand fluid flow simulation, is today providing an update on its operational plansand outlook for 2008 and beyond in the light of the recent changes inshareholdings in the Company. Flomerics' strategy remains to be a leading provider of software simulationsolutions to the worldwide engineering design market. Flomerics' softwaresolutions are targeted at the world electronic thermal management and fluid flowsoftware markets. These markets are growing strongly and the Company believes it has significantopportunities for growth. For example, data published by Global IndustryAnalysts, Inc.(1) indicates that the world electronic thermal managementsoftware market will continue to grow by 10% per year over the next five years.The Company's electronics cooling business is well positioned to benefit fromthis growth, particularly in Asia and the Far-East, which has seen strong growthin recent years. Similarly, the computer-aided engineering industry is expected to grow at acompound annual growth rate of 12% through 2009(2). The Board believesFlomerics' products can outperform this average market growth rate due to thecompetitive advantages offered by its products. Strong growth has already beenseen for the Engineering Fluid Dynamics (EFD) product range in 2007 and into2008. The investment in sales and marketing in 2007, aimed at accelerating revenuegrowth particularly from the EFD product range (acquired as part of theacquisition of Nika GmbH in 2006) is beginning to show positive results. Thisreinforces the Board's confidence that 2008 revenues will show considerableimprovement over 2007. Flomerics has cash balances of approximately £5.0m compared to £2.7m as at 31December 2007, and the Company is well funded to undertake the investment neededto deliver its strategy. Following on from the acquisitions of MicReD in 2005and Nika GmbH in 2006, additional growth through targeted acquisition remains animportant focus for the Company. The board continues to review potentialcandidates against its strategic and financial targets. The Company expects to announce its preliminary results for 2007 on 29 April. Enquiries: Flomerics Group plc +44 20 8487 3000Gary Carter, Chief ExecutiveKeith Butcher, Finance Director Conduit PR +44 20 7429 6604Christian Taylor-Wilkinson, Charlie Geller +44 7970 067320 Oriel Securities Limited +44 20 7710 7600Nominated AdviserDavid ArchAndrew Edwards For further details regarding the source information used in this announcementplease contact Charlie Geller, Conduit PR, on 0207 429 6604 -------------------------- (1) Source: PRWeb(2) Source: Daratech Inc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Jul 20177:00 amRNSGroup Trading update & Notice of HY results
10th Jul 20177:00 amRNSAcquisition of Orange County Ltd, County Durham
7th Jul 201712:26 pmRNSHolding(s) in Company
23rd Jun 20177:00 amRNSFlowtech adds technical expertise & product
26th May 20171:34 pmRNSHolding(s) in Company
25th May 201711:34 amRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
22nd May 201712:45 pmRNSIssue of Equity
8th May 20175:11 pmRNSHolding(s) in Company
26th Apr 20177:00 amRNSAnnual Financial Report & AGM
4th Apr 20177:01 amRNS2017 Q1 Trading Update
4th Apr 20177:00 amRNSFinal statement of results - year ended 31.12.16
30th Mar 201711:45 amRNSHolding(s) in Company
29th Mar 201711:33 amRNSResult of General Meeting
13th Mar 20176:07 pmRNSPosting of Circular
10th Mar 201711:06 amRNSConfirmation of successful £10 million fundraise
10th Mar 20177:15 amRNSClose of accelerated bookbuild
9th Mar 20175:03 pmRNSProposed Accelerated Bookbuild
6th Feb 20174:23 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSTrading, Acquisition, Strategy & Notice of Results
20th Jan 20177:00 amRNSAppointment of Joint Corporate Broker
8th Nov 20167:00 amRNSDirector/PDMR Shareholding
21st Sep 20167:00 amRNSHolding(s) in Company
13th Sep 20167:00 amRNS2016 HALF-YEAR REPORT - SIX MONTHS TO 30 JUNE
2nd Aug 20167:00 amRNSAcquisition, Trading Update & Notice of HY Results
30th Jun 201611:54 amRNSFlowtech-winner at 2016 Regional Business Awards
2nd Jun 20167:00 amRNSGrants under the Management Incentive Plan
1st Jun 20161:40 pmRNSResult of AGM
1st Jun 20167:00 amRNSANNUAL GENERAL MEETING - TRADING UPDATE
27th May 20167:00 amRNSHolding(s) in Company
13th May 201611:51 amRNSDirector/PDMR Shareholding
6th May 20161:59 pmRNSHolding(s) in Company
3rd May 20165:23 pmRNS2015 Annual Financial Report & Notice of AGM
12th Apr 20169:10 amRNS2015 Final results - Replacement
6th Apr 201610:31 amRNSAdoption of Financial Reporting Standard (FRS) 101
26th Feb 20161:18 pmRNSHolding(s) in Company
21st Jan 20166:04 pmRNSHolding(s) in Company
19th Jan 20164:36 pmRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update & Notice of Annual Results
21st Dec 20157:00 amRNSHolding(s) in Company
3rd Dec 20154:11 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSShare Purchases by Directors
5th Nov 20157:00 amRNSHolding(s) in Company
4th Nov 201510:09 amRNSHolding(s) in Company
3rd Nov 20157:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20157:00 amRNSHolding(s) in Company
29th Oct 20157:13 amRNSDirector Declaration
23rd Oct 20157:00 amRNSDirectorate Change
16th Sep 20158:05 amRNSDirector's Dealings
8th Sep 20157:01 amRNSEaton - Master Trading Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.